- Home
- LXEO vs EOD Comparison
LXEO vs EOD Comparison
Compare LXEO & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- EOD
- Stock Information
- Founded
- LXEO 2017
- EOD 2007
- Country
- LXEO United States
- EOD United States
- Employees
- LXEO N/A
- EOD N/A
- Industry
- LXEO
- EOD Investment Managers
- Sector
- LXEO
- EOD Finance
- Exchange
- LXEO Nasdaq
- EOD Nasdaq
- Market Cap
- LXEO 252.4M
- EOD 214.9M
- IPO Year
- LXEO 2023
- EOD N/A
- Fundamental
- Price
- LXEO $4.88
- EOD $5.03
- Analyst Decision
- LXEO Strong Buy
- EOD
- Analyst Count
- LXEO 5
- EOD 0
- Target Price
- LXEO $23.80
- EOD N/A
- AVG Volume (30 Days)
- LXEO 210.0K
- EOD 118.1K
- Earning Date
- LXEO 01-28-2025
- EOD 01-01-0001
- Dividend Yield
- LXEO N/A
- EOD 9.28%
- EPS Growth
- LXEO N/A
- EOD N/A
- EPS
- LXEO N/A
- EOD N/A
- Revenue
- LXEO N/A
- EOD N/A
- Revenue This Year
- LXEO N/A
- EOD N/A
- Revenue Next Year
- LXEO N/A
- EOD N/A
- P/E Ratio
- LXEO N/A
- EOD N/A
- Revenue Growth
- LXEO N/A
- EOD N/A
- 52 Week Low
- LXEO $4.78
- EOD $3.73
- 52 Week High
- LXEO $19.50
- EOD $4.71
- Technical
- Relative Strength Index (RSI)
- LXEO 29.67
- EOD 60.66
- Support Level
- LXEO $4.78
- EOD $4.77
- Resistance Level
- LXEO $7.66
- EOD $4.93
- Average True Range (ATR)
- LXEO 0.56
- EOD 0.08
- MACD
- LXEO -0.17
- EOD 0.02
- Stochastic Oscillator
- LXEO 3.47
- EOD 100.00
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.